AAAAAA
Results: 26-37/37
Authors:
Hirasawa, K
Jun, HS
Han, HS
Zhang, ML
Hollenberg, MD
Yoon, JW
Citation: K. Hirasawa et al., Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages, J VIROLOGY, 73(10), 1999, pp. 8541-8548
Authors:
Corvera, CU
Dery, O
McConalogue, K
Gamp, P
Thoma, M
Al-Ani, B
Caughey, GH
Hollenberg, MD
Bunnett, NW
Citation: Cu. Corvera et al., Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and-2, J PHYSL LON, 517(3), 1999, pp. 741-756
Authors:
Al-Ani, B
Saifeddine, M
Kawabata, A
Renaux, B
Mokashi, S
Hollenberg, MD
Citation: B. Al-ani et al., Proteinase-activated receptor 2 (PAR(2)): Development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands, J PHARM EXP, 290(2), 1999, pp. 753-760
Authors:
Zheng, XL
Gui, Y
Sharkey, KA
Hollenberg, MD
Citation: Xl. Zheng et al., Differential induction of nitric oxide synthase in rat gastric and vascular smooth muscle tissue: Distinct tissue distribution and distinctive signaling pathways, J PHARM EXP, 289(2), 1999, pp. 632-640
Authors:
Kawabata, A
Saifeddine, M
Al-Ani, B
Leblond, L
Hollenberg, MD
Citation: A. Kawabata et al., Evaluation of proteinase-activated receptor-1 (PAR(1)) agonists and antagonists using a cultured cell receptor desensitization assay: Activation of PAR(2) by PAR(1)-targeted ligands, J PHARM EXP, 288(1), 1999, pp. 358-370
Authors:
Sun, R
Gimbel, HV
Liu, S
Guo, DL
Hollenberg, MD
Citation: R. Sun et al., Effect of diclofenac sodium and dexamethasone on cultured human Tenon's capsule fibroblasts, OPHTHAL SUR, 30(5), 1999, pp. 382-388
Authors:
Oda, Y
Renaux, B
Bjorge, J
Saifeddine, M
Fujita, DJ
Hollenberg, MD
Citation: Y. Oda et al., cSrc is a major cytosolic tyrosine kinase in vascular tissue, CAN J PHYSL, 77(8), 1999, pp. 606-617
Authors:
Hollenberg, MD
Saifeddine, M
Al-Ani, B
Gui, Y
Citation: Md. Hollenberg et al., Proteinase-activated receptor 4 (PAR(4)): action of PAR(4)-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR(1) and PAR(2), CAN J PHYSL, 77(6), 1999, pp. 458-464
Authors:
Al-Ani, B
Saifeddine, M
Kawabata, A
Hollenberg, MD
Citation: B. Al-ani et al., Proteinase activated receptor 2: role of extracellular loop 2 for ligand-mediated activation, BR J PHARM, 128(5), 1999, pp. 1105-1113
Authors:
Vergnolle, N
Hollenberg, MD
Sharkey, KA
Wallace, JL
Citation: N. Vergnolle et al., Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR(2))-activating peptides in the rat paw, BR J PHARM, 127(5), 1999, pp. 1083-1090
Authors:
Vergnolle, N
Hollenberg, MD
Wallace, JL
Citation: N. Vergnolle et al., Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR(1)), BR J PHARM, 126(5), 1999, pp. 1262-1268
Authors:
Saifeddine, M
Roy, SS
Al-Ani, B
Triggle, CR
Hollenberg, MD
Citation: M. Saifeddine et al., Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor, BR J PHARM, 125(7), 1998, pp. 1445-1454